Manufacturers Life Insurance Company, The Rhythm Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $103 Billion
- Q1 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 47,624 shares of RYTM stock, worth $2.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,624
Previous 39,238
21.37%
Holding current value
$2.01 Million
Previous $1.8 Million
14.42%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding RYTM
# of Institutions
176Shares Held
62.4MCall Options Held
880KPut Options Held
84.1K-
Primecap Management CO Pasadena, CA7.75MShares$328 Million0.25% of portfolio
-
Black Rock Inc. New York, NY6.53MShares$276 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$271 Million3.51% of portfolio
-
Goldman Sachs Group Inc New York, NY5.11MShares$216 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.3MShares$140 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.36B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...